| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 13 |
| 1 | ETOPOSIDE | 12 |
| 2 | INFLIXIMAB | 10 |
| 3 | CISPLATIN | 9 |
| 4 | IFOSFAMIDE FOR INJECTION | 9 |
| 5 | METHOTREXATE | 9 |
| 6 | METHOTREXATE SODIUM | 9 |
| 7 | PREDNISONE | 9 |
| 8 | TERIPARATIDE | 9 |
| 9 | ALENDRONATE SODIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METEX | 2 | 0.0053 |
| 1 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 2 | 0.0045 |
| 2 | DEXRAZOXANE FOR INJECTION | 2 | 0.0021 |
| 3 | CHLOROTHIAZIDE SODIUM | 1 | 0.0011 |
| 4 | TRABECTEDIN | 2 | 0.0009 |
| 5 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 6 | HALOBETASOL PROPIONATE | 1 | 0.0007 |
| 7 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 8 | VINBLASTINE SULFATE | 1 | 0.0005 |
| 9 | IFOSFAMIDE FOR INJECTION | 9 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 19 |
| 1 | Corticosteroid [EPC] | 16 |
| 2 | Alkylating Drug [EPC] | 13 |
| 3 | Topoisomerase Inhibitor [EPC] | 12 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 10 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 9 |
| 6 | Parathyroid Hormone Analog [EPC] | 9 |
| 7 | Platinum-based Drug [EPC] | 9 |
| 8 | Kinase Inhibitor [EPC] | 8 |
| 9 | Thiazide Diuretic [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Recombinant Human Growth Hormone [EPC] | 4 | 0.0002 |
| 2 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 3 | Topoisomerase Inhibitor [EPC] | 12 | 0.0002 |
| 4 | Influenza A M2 Protein Inhibitor [EPC] | 2 | 0.0001 |
| 5 | Nitrofuran Antibacterial [EPC] | 2 | 0.0001 |
| 6 | Interleukin-17A Antagonist [EPC] | 4 | 0.0001 |
| 7 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 8 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Parathyroid Hormone Analog [EPC] | 9 | 0.0001 |